FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 303:1202-1208 November 20, 1980 Number 21 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Since many women with phenylketonuria (PKU) will have children of their own, we were interested in ascertaining the effect of maternal PKU and hyperphenylalaninemia on the offspring of such women. We reviewed the literature on this subject and obtained additional unpublished data through an international survey. Data were collected on 524 pregnancies in 155 women; in 34 pregnancies a low-phenylalanine diet was begun after or shortly before pregnancy was established. Among untreated pregnancies, the frequencies of mental retardation, microcephaly, and congenital heart disease were greatly increased over those in the normal population, and these increases correlated with the mother's blood levels of phenylalanine. Ninety-five per cent of mothers with blood phenylalanine concentrations of 20 mg per deciliter or higher had at least one mentally retarded child. Bias introduced by case-finding methods cannot explain these results. It is not clear from our review whether dietary treatment begun after conception is helpful, but treatment begun before conception should be evaluated.

This article has been cited by other articles:

• Moseley, K., Skrabal, J., Yano, S., Koch, R. (2009). Sapropterin Dihydrochloride (6R-BH4) and Maternal Phenylketonuria Two Case Studies. ICAN: Infant, Child, & Adolescent Nutrition 1: 262-266 [Abstract]  
• Koch, R. (2008). Maternal Phenylketonuria and Tetrahydrobiopterin. Pediatrics 122: 1367-1368 [Full Text]  
• Maillot, F., Lilburn, M., Baudin, J., Morley, D. W, Lee, P. J (2008). Factors influencing outcomes in the offspring of mothers with phenylketonuria during pregnancy: the importance of variation in maternal blood phenylalanine. Am. J. Clin. Nutr. 88: 700-705 [Abstract] [Full Text]  
• Committee on Genetics, (2008). Maternal Phenylketonuria. Pediatrics 122: 445-449 [Abstract] [Full Text]  
• Jenkins, K. J., Correa, A., Feinstein, J. A., Botto, L., Britt, A. E., Daniels, S. R., Elixson, M., Warnes, C. A., Webb, C. L. (2007). Noninherited Risk Factors and Congenital Cardiovascular Defects: Current Knowledge: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics. Circulation 115: 2995-3014 [Abstract] [Full Text]  
• Varma, S. K. (2004). Maternal PKU Effects on Congenital Anomalies and Developmental Outcome of Offspring. AAP Grand Rounds 12: 17-18 [Full Text]  
• Levy, H. L. (2003). Historical Background for the Maternal PKU Syndrome. Pediatrics 112: 1516-1518 [Abstract] [Full Text]  
• Koch, R., Hanley, W., Levy, H., Matalon, K., Matalon, R., Rouse, B., Trefz, F., Guttler, F., Azen, C., Platt, L., Waisbren, S., Widaman, K., Ning, J., Friedman, E. G., de la Cruz, F. (2003). The Maternal Phenylketonuria International Study: 1984-2002. Pediatrics 112: 1523-1529 [Abstract] [Full Text]  
• Matalon, K. M., Acosta, P. B., Azen, C. (2003). Role of Nutrition in Pregnancy With Phenylketonuria and Birth Defects. Pediatrics 112: 1534-1536 [Abstract] [Full Text]  
• Widaman, K. F., Azen, C. (2003). Relation of Prenatal Phenylalanine Exposure to Infant and Childhood Cognitive Outcomes: Results From the International Maternal PKU Collaborative Study. Pediatrics 112: 1537-1543 [Abstract] [Full Text]  
• Levy, H. L., Waisbren, S. E., Guttler, F., Hanley, W. B., Matalon, R., Rouse, B., Trefz, F. K., de la Cruz, F., Azen, C. G., Koch, R. (2003). Pregnancy Experiences in the Woman With Mild Hyperphenylalaninemia. Pediatrics 112: 1548-1552 [Abstract] [Full Text]  
• Clarke, J. T.R. (2003). The Maternal Phenylketonuria Project: A Summary of Progress and Challenges for the Future. Pediatrics 112: 1584-1587 [Abstract] [Full Text]  
• (2002). Barriers to Dietary Control Among Pregnant Women With Phenylketonuria--United States, 1998-2000. JAMA 287: 1258-1259 [Full Text]  
• Acosta, P. B, Matalon, K., Castiglioni, L., Rohr, F. J, Wenz, E., Austin, V., Azen, C. (2001). Intake of major nutrients by women in the Maternal Phenylketonuria (MPKU) Study and effects on plasma phenylalanine concentrations. Am. J. Clin. Nutr. 73: 792-796 [Abstract] [Full Text]  
• Committee on Genetics, (2001). Maternal Phenylketonuria. Pediatrics 107: 427-428 [Abstract] [Full Text]  
• Oberdoerster, J., Guizzetti, M., Costa, L. G. (2000). Effect of Phenylalanine and Its Metabolites on the Proliferation and Viability of Neuronal and Astroglial Cells: Possible Relevance in Maternal Phenylketonuria. J. Pharmacol. Exp. Ther. 295: 295-301 [Abstract] [Full Text]  
• Waisbren, S. E., Hanley, W., Levy, H. L., Shifrin, H., Allred, E., Azen, C., Chang, P.-N., Cipcic-Schmidt, S., de la Cruz, F., Hall, R., Matalon, R., Nanson, J., Rouse, B., Trefz, F., Koch, R. (2000). Outcome at Age 4 Years in Offspring of Women With Maternal Phenylketonuria: The Maternal PKU Collaborative Study. JAMA 283: 756-762 [Abstract] [Full Text]  
• Austic, R. E, Su, C.-L., Strupp, B. J, Levitsky, D. A (1999). Effects of dietary mixtures of amino acids on fetal growth and maternal and fetal amino acid pools in experimental maternal phenylketonuria. Am. J. Clin. Nutr. 69: 687-696 [Abstract] [Full Text]  
• Levy, H. L. (1999). Phenylketonuria: Old disease, new approach to treatment. Proc. Natl. Acad. Sci. USA 96: 1811-1813 [Full Text]  
• Scriver, C. R. (1998). A Simple Phenylalanine Method for Detecting Phenylketonuria in Large Populations of Newborn Infants, by Robert Guthrie and Ada Susi, Pediatrics, 1963;32:318-343. Pediatrics 102: 236-237 [Abstract] [Full Text]  
• Choi, D., Ward, S., Messaddeq, N, Launay, J., Maroteaux, L (1997). 5-HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells. Development 124: 1745-1755 [Abstract]  
• Gleason, L. A., Michals, K., Matalon, R., Langenberg, P., Kamath, S. (1992). A Treatment Program for Adolescents With Phenylketonuria. CLIN PEDIATR 31: 331-335 [Abstract]  
• Greenspoon, J. S., Morgan, B. R. (1991). A Product Warning Label to Encourage Prepregnancy Control of Diabetes. JAMA 266: 2225-2225 [Abstract]  
• Azen, C. G., Koch, R., Friedman, E. G., Berlow, S., Coldwell, J., Krause, W., Matalon, R., McCabe, E., O'Flynn, M., Peterson, R., Rouse, B., Scott, C. R., Sigman, B., Valle, D., Warner, R. (1991). Intellectual Development in 12-Year-Old Children Treated for Phenylketonuria. Arch Pediatr Adolesc Med 145: 35-39 [Abstract]  
• Lin, A. E., Chin, A. J., Devine, W., Park, S. C., Zackai, E. (1987). The Pattern of Cardiovascular Malformation in the CHARGE Association. Arch Pediatr Adolesc Med 141: 1010-1013 [Abstract]  
• Lacey, D. J., Terplan, K. (1987). Abnormal Cerebral Cortical Neurons in a Child With Maternal PKU Syndrome. J Child Neurol 2: 201-204 [Abstract]  
• AMBRUS, C. M., ANTHONE, S., HORVATH, C., KALGHATGI, K., LELE, A. S., EAPEN, G., AMBRUS, J. L., RYAN, A. J., LI, P. (1987). Extracorporeal Enzyme Reactors for Depletion of Phenylalanine in Phenylketonuria. ANN INTERN MED 106: 531-537 [Abstract]  
• Woo, S. L. C., Lidsky, A. S., Guttler, F., Thirumalachary, C., Robson, K. J. H. (1984). Prenatal Diagnosis of Classical Phenylketonuria by Gene Mapping. JAMA 251: 1998-2002 [Abstract]  
• Tenbrinck, M. S., Stroud, H. W. (1982). Normal Infant Born to a Mother With Phenylketonuria. JAMA 247: 2139-2140 [Abstract]  
• Alm, J., Larsson, A., Rosenqvist, U. (1982). Health Economic Analysis of the Swedish Neonatal Metabolic Screening Programme: A Method of Optimizing Routines. Med Decis Making 2: 33-45